XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Impact of CECL Adoption
[1]
Common Stock
Additional Paid-in Capital
Accumulated Retained Earnings
Accumulated Retained Earnings
Impact of CECL Adoption
[1]
Accumulated Other Comprehensive Income (Loss)
Balance at Dec. 31, 2018 $ 1,969,697   $ 617 $ 1,674,274 $ 300,407   $ (5,601)
Balance (in shares) at Dec. 31, 2018     62,480,755        
Increase (Decrease) in Stockholders' Equity              
Net income 118,620       118,620    
Other comprehensive income 35,796           35,796
Repurchase and retirement of common stock (100,000)   $ (33) (89,887) (10,080)    
Repurchase and retirement of common stock (in shares)     (3,364,761)        
Cash dividends declared (40,807)       (40,807)    
Dividend equivalents declared 0     89 (89)    
Share-based compensation expense 7,927     7,927      
Issuance of restricted stock, net 0            
Issuance of restricted stock, net (in shares)     316,254        
Restricted stock surrendered and canceled (2,629)     (2,629)      
Restricted stock surrendered and canceled (in shares)     (111,456)        
Exercise of stock options 394     394      
Exercise of stock options (in shares)     43,548        
Balance at Sep. 30, 2019 1,988,998   $ 584 1,590,168 368,051   30,195
Balance (in shares) at Sep. 30, 2019     59,364,340        
Balance at Dec. 31, 2018 1,969,697   $ 617 1,674,274 300,407   (5,601)
Balance (in shares) at Dec. 31, 2018     62,480,755        
Balance at Dec. 31, 2019 $ 2,012,594 $ (45,625) $ 586 1,594,434 396,051 $ (45,625) 21,523
Balance (in shares) at Dec. 31, 2019 59,506,057   59,506,057        
Increase (Decrease) in Stockholders' Equity              
Accounting standards update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member            
Balance at Jun. 30, 2019 $ 1,984,456   $ 595 1,618,137 343,366   22,358
Balance (in shares) at Jun. 30, 2019     60,509,994        
Increase (Decrease) in Stockholders' Equity              
Net income 41,375       41,375    
Other comprehensive income 7,837           7,837
Repurchase and retirement of common stock (34,031)   $ (11) (30,634) (3,386)    
Repurchase and retirement of common stock (in shares)     (1,145,515)        
Cash dividends declared (13,266)       (13,266)    
Dividend equivalents declared 0     38 (38)    
Share-based compensation expense 2,614     2,614      
Issuance of restricted stock, net 0            
Issuance of restricted stock, net (in shares)     11,500        
Restricted stock surrendered and canceled 0            
Restricted stock surrendered and canceled (in shares)     (12,250)        
Exercise of stock options 13     13      
Exercise of stock options (in shares)     611        
Balance at Sep. 30, 2019 1,988,998   $ 584 1,590,168 368,051   30,195
Balance (in shares) at Sep. 30, 2019     59,364,340        
Balance at Dec. 31, 2019 $ 2,012,594 $ (45,625) $ 586 1,594,434 396,051 $ (45,625) 21,523
Balance (in shares) at Dec. 31, 2019 59,506,057   59,506,057        
Increase (Decrease) in Stockholders' Equity              
Net income $ (6,785)       (6,785)    
Other comprehensive income 24,140           24,140
Cash dividends declared (53,464)       (53,464)    
Dividend equivalents declared 0     217 (217)    
Share-based compensation expense 7,747     7,747      
Issuance of restricted stock, net 0            
Issuance of restricted stock, net (in shares)     493,411        
Issuance of common stock - acquisition 749,603   $ 344 749,259      
Issuance of common stock - acquisition (in shares)     34,407,403        
Restricted stock surrendered and canceled (1,372)     (1,372)      
Restricted stock surrendered and canceled (in shares)     (102,486)        
Exercise of stock options 1,247     1,247      
Exercise of stock options (in shares)     71,136        
Balance at Sep. 30, 2020 $ 2,688,085   $ 930 2,351,532 289,960   45,663
Balance (in shares) at Sep. 30, 2020 94,375,521   94,375,521        
Balance at Jun. 30, 2020 $ 2,654,647   $ 930 2,348,415 247,078   58,224
Balance (in shares) at Jun. 30, 2020     94,350,902        
Increase (Decrease) in Stockholders' Equity              
Net income 66,566       66,566    
Other comprehensive income (12,561)           (12,561)
Cash dividends declared (23,590)       (23,590)    
Dividend equivalents declared 0     94 (94)    
Share-based compensation expense 2,899     2,899      
Issuance of restricted stock, net 0            
Issuance of restricted stock, net (in shares)     19,902        
Issuance of common stock - acquisition 0            
Issuance of common stock - acquisition (in shares)     0        
Restricted stock surrendered and canceled (99)     (99)      
Restricted stock surrendered and canceled (in shares)     (8,180)        
Exercise of stock options 223     223      
Exercise of stock options (in shares)     12,897        
Balance at Sep. 30, 2020 $ 2,688,085   $ 930 $ 2,351,532 $ 289,960   $ 45,663
Balance (in shares) at Sep. 30, 2020 94,375,521   94,375,521        
[1] Related to the adoption of Accounting Standards Update 2016-13Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. See Note 2 - Recently Issue Accounting Pronouncements for further discussion.